{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:09:25Z","timestamp":1764601765959,"version":"3.37.3"},"reference-count":16,"publisher":"Zhejiang University Press","issue":"8","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670148"],"award-info":[{"award-number":["81670148"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Health Science and Technology Project of Zhejiang Province,China","award":["2012KYB079"],"award-info":[{"award-number":["2012KYB079"]}]}],"content-domain":{"domain":["springerlink.com","jzus.zju.edu.cn"],"crossmark-restriction":true},"short-container-title":["J. Zhejiang Univ. Sci. B"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1631\/jzus.b2000532","type":"journal-article","created":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T07:06:46Z","timestamp":1630134406000},"page":"695-700","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Successful treatment of refractory pure red cell aplasia with eltrombopag after ABO-incompatible allogeneic hematopoietic stem cell transplantation","\u827e\u66f2\u6ce2\u5e15\u6210\u529f\u6cbb\u7597ABO\u8840\u578b\u4e0d\u5408\u7684\u5f02\u57fa\u56e0\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u540e\u96be\u6cbb\u6027\u7eaf\u7ea2\u7ec6\u80de\u518d\u751f\u969c\u788d\u6027\u8d2b\u8840"],"prefix":"10.1631","volume":"22","author":[{"given":"Yang","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huarui","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2723-1621","authenticated-orcid":false,"given":"He","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3857-5574","authenticated-orcid":false,"given":"Yanmin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"635","published-online":{"date-parts":[[2021,8,28]]},"reference":[{"issue":"19","key":"540_CR1","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1182\/blood-2018-11-884486","volume":"133","author":"LJ Alvarado","year":"2019","unstructured":"Alvarado LJ, Huntsman HD, Cheng H, et al., 2019. Eltrombopag maintains human hematopoietic stem and progenitor cells under inflammatory conditions mediated by IFN-\u03b3. Blood, 133(19):2043\u20132055. https:\/\/doi.org\/10.1182\/blood-2018-11-884486","journal-title":"Blood"},{"issue":"22","key":"540_CR2","doi-asserted-by":"publisher","first-page":"4639","DOI":"10.1182\/blood-2010-04-281717","volume":"116","author":"WL Bao","year":"2010","unstructured":"Bao WL, Bussel JB, Heck S, et al., 2010. Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents. Blood, 116(22):4639\u20134645. https:\/\/doi.org\/10.1182\/blood-2010-04-281717","journal-title":"Blood"},{"issue":"8","key":"540_CR3","doi-asserted-by":"publisher","first-page":"E216","DOI":"10.1002\/ajh.25515","volume":"94","author":"S Bathini","year":"2019","unstructured":"Bathini S, Holtzman NG, Koka R, et al., 2019. Refractory postallogeneic stem cell transplant pure red cell aplasia in remission after treatment with daratumumab. Am J Hematol, 94(8):E216\u2013E219. https:\/\/doi.org\/10.1002\/ajh.25515","journal-title":"Am J Hematol"},{"issue":"8","key":"540_CR4","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.bbmt.2018.04.022","volume":"24","author":"A Busca","year":"2018","unstructured":"Busca A, Dellacasa C, Giaccone L, et al., 2018. Eltrombopag for the treatment of refractory pure RBC aplasia after major ABO incompatible hematopoietic stem cell transplantation. Biol Blood Marrow Transplant, 24(8):1765\u20131770. https:\/\/doi.org\/10.1016\/j.bbmt.2018.04.022","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"540_CR5","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1182\/blood-2013-10-534743","volume":"123","author":"R Desmond","year":"2014","unstructured":"Desmond R, Townsley DM, Dumitriu B, et al., 2014. Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug. Blood, 123(12):1818\u20131825. https:\/\/doi.org\/10.1182\/blood-2013-10-534743","journal-title":"Blood"},{"issue":"11","key":"540_CR6","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1007\/s00277-020-04106-2","volume":"99","author":"F Gao","year":"2020","unstructured":"Gao F, Zhou XY, Shi JM, et al., 2020. Eltrombopag treatment promotes platelet recovery and reduces platelet transfusion for patients with post-transplantation thrombocytopenia. Ann Hematol, 99(11):2679\u20132687. https:\/\/doi.org\/10.1007\/s00277-020-04106-2","journal-title":"Ann Hematol"},{"key":"540_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exphem.2019.03.002","volume":"73","author":"KL Guenther","year":"2019","unstructured":"Guenther KL, Cheruku PS, Cash A, et al., 2019. Eltrombopag promotes DNA repair in human hematopoietic stem and progenitor cells. Exp Hematol, 73:1\u20136.e6. https:\/\/doi.org\/10.1016\/j.exphem.2019.03.002","journal-title":"Exp Hematol"},{"issue":"7","key":"540_CR8","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.bbmt.2013.04.004","volume":"19","author":"M Hirokawa","year":"2013","unstructured":"Hirokawa M, Fukuda T, Ohashi K, et al., 2013. Efficacy and long-term outcome of treatment for pure red cell aplasia after allogeneic stem cell transplantation from major ABO-incompatible donors. Biol Blood Marrow Transplant, 19(7):1026\u20131032. https:\/\/doi.org\/10.1016\/j.bbmt.2013.04.004","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"540_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1200931","volume":"367","author":"MJ Olnes","year":"2012","unstructured":"Olnes MJ, Scheinberg P, Calvo KR, et al., 2012. Eltrombopag and improved hematopoiesis in refractory aplastic anemia. N Engl J Med, 367(1):11\u201319. https:\/\/doi.org\/10.1056\/NEJMoa1200931","journal-title":"N Engl J Med"},{"issue":"1","key":"540_CR10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/jca.21553","volume":"33","author":"K Sackett","year":"2018","unstructured":"Sackett K, Cohn CS, Fahey-Ahrndt K, et al., 2018. Successful treatment of pure red cell aplasia because of ABO major mismatched stem cell transplant. J Clin Apher, 33(1):108\u2013112. https:\/\/doi.org\/10.1002\/jca.21553","journal-title":"J Clin Apher"},{"issue":"6","key":"540_CR11","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/sj.bmt.1701384","volume":"22","author":"C Selleri","year":"1998","unstructured":"Selleri C, Raiola A, de Rosa G, et al., 1998. CD34+-enriched donor lymphocyte infusions in a case of pure red cell aplasia and late graft failure after major ABO-incompatible bone marrow transplantation. Bone Marrow Transplant, 22(6):605\u2013607. https:\/\/doi.org\/10.1038\/sj.bmt.1701384","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"540_CR12","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/tme.12216","volume":"25","author":"JL Shahan","year":"2015","unstructured":"Shahan JL, Hildebrandt GC, 2015. Successful treatment of refractory pure red cell aplasia with bortezomib after allogeneic haematopoietic cell transplantation in a patient with alpha-beta subcutaneous panniculitis-like T cell lymphoma. Transfus Med, 25(5):342\u2013344. https:\/\/doi.org\/10.1111\/tme.12216","journal-title":"Transfus Med"},{"issue":"17","key":"540_CR13","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1182\/blood-2016-10-740241","volume":"130","author":"E Vlachodimitropoulou","year":"2017","unstructured":"Vlachodimitropoulou E, Chen YL, Garbowski M, et al., 2017. Eltrombopag: a powerful chelator of cellular or extracellular iron(III) alone or combined with a second chelator. Blood, 130(17):1923\u20131933. https:\/\/doi.org\/10.1182\/blood-2016-10-740241","journal-title":"Blood"},{"issue":"4","key":"540_CR14","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/tme.12143","volume":"24","author":"X Yang","year":"2014","unstructured":"Yang X, Levis M, 2014. Pulsed-high-dose dexamethasone as a treatment for pure red cell aplasia following ABO-incompatible allogeneic stem cell transplantation. Transfus Med, 24(4):246\u2013248. https:\/\/doi.org\/10.1111\/tme.12143","journal-title":"Transfus Med"},{"issue":"21","key":"540_CR15","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1182\/blood-2018-01-826784","volume":"131","author":"Z Zhao","year":"2018","unstructured":"Zhao Z, Sun Q, Sokoll LJ, et al., 2018. Eltrombopag mobilizes iron in patients with aplastic anemia. Blood, 131(21):2399\u20132402. https:\/\/doi.org\/10.1182\/blood-2018-01-826784","journal-title":"Blood"},{"issue":"4","key":"540_CR16","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.1365-3148.2012.01156.x","volume":"22","author":"W Zhidong","year":"2012","unstructured":"Zhidong W, Hongmin Y, Hengxiang W, 2012. Successful treatment of pure red cell aplasia with a single low dose of rituximab in two patients after major ABO incompatible peripheral blood allogeneic stem cell transplantation. Transfus Med, 22(4):302\u2013304. https:\/\/doi.org\/10.1111\/j.1365-3148.2012.01156.x","journal-title":"Transfus Med"}],"container-title":["Journal of Zhejiang University-SCIENCE B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B2000532.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1631\/jzus.B2000532\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B2000532.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T08:31:21Z","timestamp":1637569881000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1631\/jzus.B2000532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["540"],"URL":"https:\/\/doi.org\/10.1631\/jzus.b2000532","relation":{},"ISSN":["1673-1581","1862-1783"],"issn-type":[{"type":"print","value":"1673-1581"},{"type":"electronic","value":"1862-1783"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"https:\/\/orcid.org\/0000-0003-3857-5574","URL":"http","order":0,"name":"name","label":"Yanmin ZHAO","group":{"name":"orcid","label":"ORCID"}},{"value":"https:\/\/orcid.org\/0000-0002-2723-1621","URL":"http","order":1,"name":"name","label":"He HUANG","group":{"name":"orcid","label":"ORCID"}},{"value":"2020-09-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-15","order":2,"name":"crosschecked","label":"Crosschecked","group":{"name":"publication_history","label":"Publication History"}},{"value":"Correspondence","order":0,"name":"content_type","group":{"name":"content_type","label":"Content Type"}},{"value":"\u00a9 Zhejiang University Press 2021","order":0,"name":"copyright","group":{"name":"copyright","label":"Copyright"}}]}}